Piper Sandler Reiterates Overweight Rating on I-Mab (IMAB)
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro reiterated an Overweight rating and $8.00 price target on I-Mab (NASDAQ: IMAB).The analyst commented, "At ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


